openPR Logo
Press release

Macrolide Antibiotics Market Analysis 2018 to 2024: Growth in Skin Infections the +12.7% CAGR Industry

02-23-2018 05:54 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Macrolide Antibiotics Market ? Industry Trends and Forecast to 2024

Global Macrolide Antibiotics Market ? Industry Trends and Forecast to 2024

Macrolide Antibiotics Market Report 2018 added by Data Bridge Market Research explores Global Macrolide Antibiotics Market size, share and growth with forecast to 2024.

Global Macrolide Antibiotics Market accounted to grow at a CAGR of 12.7% during the forecast period of 2017 to 2024.

Global Macrolide Antibiotics Market Company Analysis:

Merck Co. & Inc., Pfizer Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Bayer AG, Abbott.

Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-macrolide-antibiotics-market

Global Macrolide Antibiotics Market By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin), By Route of Administration (Oral, Parenteral), By Infection (Mycoplasma pneumoniae, Legionella sp., Or Bordetella pertussis,Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis, Uncomplicated Skin Infections), By End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Center, Research Laboratories), By Geography – Industry Trends and Forecast to 2024

Report Definition:

Macrolides are a class of antibiotics derived from Saccharopolyspora erythraea. They inhibit protein synthesis in bacteria by binding to the 50S ribosomal element and effective against gram positive bacteria and intracellular pathogens such as Legionella, Mycoplasma and Chlamydia. It primarily acts as a bacteriostatic agent against many strains of Corynebacteria, listeria, Moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia and Haemophilus sp.

Some of the major players operating in Global Macrolide Antibiotics Market Report are:

• Novartis AG
• Sanofi
• AstraZeneca
• F. Hoffmann-La Roche AG
• Cempra, Inc.
• Macrolide Pharmaceuticals, Inc.
• SM Biomed
• Barkat Pharmaceutical Group
• Active Pharmaceutical Ingredient Manufacturing
• Mustafa NevzatİlaçSanayii A.Ş.
• Zhejiang Guobang Pharmaceutical Co., Ltd.
• Tianyin Pharmaceutical Co., Inc.
• Japan Pharmaceutical Manufacturers Association (JPMA)
• Murli Krishna Pharma among others.

For More Details In-Depth Enquiry @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-macrolide-antibiotics-market

Report Segmentation:

1. The global macrolide antibiotics market is segmented by drugs into azithromycin, clarithromycin, erythromycin, fidaxomicinand telithromycin.

2. On the basis of route of administration the market is segmented into oral and parenteral.

3. On the basis of indication the market is segmented into infection due to Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis,symptomatic cat-scratch disease, Bacillaryangiomatosis, Peliosishepatis in patients with AIDS, cerebral toxoplasmosis, uncomplicated skin infections and others.

4. On the basis of end user, the market is segmented into hospital, dermatology clinic, clinic, ambulatory center, research laboratories.

Geographical Segmentation:

On the basis of geography, global macrolide antibiotics market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, andBrazil among others. In 2017, North America is expected to dominate the market.

Report Drivers and Restraints:

• Growth in skin infections.
• Rise in demand of drugs against bacterial skin infections.
• Macrolide antibiotics increase the risk of sudden cardiac death.

Speak to Analyst @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-macrolide-antibiotics-market

Key Questions Answered in Global Macrolide Antibiotics Market Report:-

Our Report offers:-

 What will the market growth rate, Overview and Analysis by Type of Global Macrolide Antibiotics Market in 2024?

 What are the key factors driving, Analysis by Applications and Countries Global Macrolide Antibiotics Market?

 What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Global Macrolide Antibiotics Market?

 Who are Opportunities, Risk and Driving Force of Global Macrolide Antibiotics Market?
 Who are the opportunities and threats faced by the vendors in Global Macrolide Antibiotics Market? Business Overview by Type, Applications, Gross Margin and Market Share

 What are the Global Macrolide Antibiotics Market opportunities, market risk and market overview of the Market?

Related Report

Global Pen Needles Market – Industry Trends and Forecast to 2024

Global Pen Needles Market, By Product Type (Standard Pen Needles, Safety Pen Needles), By Product Length (Nano Length, Medium Length, Long length), By Usability (Reusable Pen Needles, Disposable Pen Needles), By Application (Diabetes, Growth Hormone Deficiency, Others), By Therapy (Insulin, Glucagon-like peptide-1, Growth Hormones), By End-User (Hospitals, Clinics, OTC, Home Healthcare, Others), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-pen-needles-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Macrolide Antibiotics Market Analysis 2018 to 2024: Growth in Skin Infections the +12.7% CAGR Industry here

News-ID: 954499 • Views:

More Releases from Data Bridge Market Research

Piriformis Syndrome Treatment Market Size to Reach USD 418.25 million by 2033, Growing at a CAGR of 6.00% During 2026-2033
Piriformis Syndrome Treatment Market Size to Reach USD 418.25 million by 2033, G …
As per Data Bridge Market Research analysis, the Piriformis Syndrome Treatment Market was estimated at USD 0.26 billion in 2025. The market is expected to grow from USD 262.42 million in 2025 to USD 418.25 million by 2033, at a CAGR of 6.00% during the forecast period with driven by the rising demand for minimally invasive pain management therapies, increasing prevalence of musculoskeletal disorders, advancements in diagnostic imaging, and growing
Neurological Disorder Drugs Market Outlook (2026-2032): 5.9% CAGR Driving Growth from USD 105.76 Billion to USD 149.17 Billion
Neurological Disorder Drugs Market Outlook (2026-2032): 5.9% CAGR Driving Growth …
"As per Data Bridge Market Research analysis, the Neurological Disorder Drugs Market was estimated at USD 99.86 billion in 2025. The market is expected to grow from USD 105.76 billion in 2026 to USD 149.17 billion in 2032, at a CAGR of 5.9% during the forecast period with driven by the rising demand for advanced neurotherapeutics, increasing prevalence of neurological diseases, and expanding adoption of targeted biologics and precision medicine
Etanercept Market Size, Share & Industry Trends Analysis Report, 2026-2033: Market Expected to Reach USD 26.81 Billion by 2033 at a CAGR of 3.7%
Etanercept Market Size, Share & Industry Trends Analysis Report, 2026-2033: Mark …
As per Data Bridge Market Research analysis, the Etanercept Market was estimated at USD 20.05 billion in 2025. The market is expected to grow from USD 20.79 billion in 2026 to USD 26.81 billion in 2033, at a CAGR of 3.7% during the forecast period with driven by the rising demand for biologic therapies for autoimmune disorders, expanding biosimilar adoption, increasing prevalence of rheumatoid arthritis and psoriasis, and continuous advancements
E-Clinical Solutions Market Size, Share & Industry Analysis, By Product, Deployment, End-User, and Regional Forecast, 2026-2032 | Market Expected to Reach USD 25.79 Billion by 2032 at a CAGR of 13.50%
E-Clinical Solutions Market Size, Share & Industry Analysis, By Product, Deploym …
As per Data Bridge Market Research analysis, the E-Clinical Solutions Market was estimated at USD 10.62 billion in 2025. The market is expected to grow from USD 12.06 billion in 2026 to USD 25.79 billion in 2032, at a CAGR of 13.50% during the forecast period, driven by the rising demand for decentralized clinical trials, increasing adoption of cloud-based clinical data management platforms, growing pharmaceutical R&D investments, and expanding integration

All 5 Releases


More Releases for Macrolide

Emerging Sub-Segments Transforming the Macrolide Antibiotics Market Landscape
The macrolide antibiotics market is on track for impressive growth in the coming years, driven by evolving healthcare needs and advancements in treatment approaches. This sector is experiencing increasing demand due to various healthcare challenges and improving access to medications globally. Below is a detailed overview of the market's size, key players, trends, and segmentation. Anticipated Market Expansion in the Macrolide Antibiotics Sector by 2030 The macrolide antibiotics market is
Rising Prevalence Of Skin Infections Fuels Growth In The Macrolide Antibiotics M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Macrolide Antibiotics Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a quick expansion in the market size of macrolide antibiotics. It is projected to surge from $59.07 billion in 2024 to $66.02 billion in 2025, with a Compound Annual Growth Rate (CAGR)
Macrolide Drugs Market: A Comprehensive Overview
The global macrolide drugs market was valued at approximately USD 5.60 billion in 2024 and is expected to reach around USD 6.82 billion by 2033, growing at a compound annual growth rate (CAGR) of 2.0% from 2025 to 2033. Macrolide Drugs Market Overview Macrolide antibiotics, including azithromycin, clarithromycin, and erythromycin, are widely used in the treatment of respiratory tract infections, skin infections, and sexually transmitted diseases. Their broad-spectrum activity and favorable safety
Emerging Macrolide Antibiotics Market Trend 2025-2034: Growing Emphasis On Gener …
"How Is the Macrolide Antibiotics Market Projected to Grow, and What Is Its Market Size? The market size for macrolide antibiotics has seen a swift expansion in the past few years. It is expected to elevate from a value of $59.07 billion in 2024 to $66.02 billion in 2025, marking a compound annual growth rate (CAGR) of 11.8%. The preceding period's growth is associated with factors like escalating antibiotic resistance, authorization
Defending Health: Global Macrolide Antibiotics Market Analysis 2023-2031
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: Macrolide antibiotics have long been stalwarts in the fight against bacterial infections, offering potent and versatile solutions to a wide range of ailments. As the world faces evolving challenges in infectious disease management, the global macrolide antibiotics market is poised to undergo significant growth, driven by technological advancements, increasing antibiotic resistance, and the impact of the COVID-19 pandemic. 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Macrolide Antibiotics Market Greater Revenue Share by 2026(Macrolide Antibiotics …
Macrolide Antibiotics are bacteriostatic in nature with a broad spectrum of activity against many gram-positive bacteria. Macrolide Antibiotics are primarily useful in treating soft tissue, respiratory condition, sexually transmitted and atypical mycobacterial infections. Macrolide Antibiotics also possess anti-inflammatory and immunomodulatory effects which are used for certain health conditions. Macrolide Antibiotics are considered to be both first line and second line of treatment, it mainly depends on the conditions it is